For COVID-19 vaccine updates, please review our information guide and sign up for Connect. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
The availability of new monoclonal antibodies and novel targeted therapies for chronic lymphocytic leukemia has greatly increased the complexity of treating symptomatic patients. Richard Furman, M.D. joins a panel of doctors and researchers in this OncLive video.
New lease on life: Bob Azopardi with his oncologist, Dr. Richard Furman.
Prognostic models can have ‘tremendous impact’ on long-term outcomes in CLL
Medical Marvels: Life-saving treatment for chronic leukemia
A discussion about treatments for CLL/SLL
CLL Research Highlights From ASH 2015
Changing Treatment Landscape in CLL
Optimizing Treatment With Ibrutinib in High-Risk CLL
Furman discusses treatment options for patients with CLL
Role of Transplantation in High-Risk CLL
